In a development that will dilute U.S. Attorney General Jeff Sessions’ stance on marijuana enforcement, President Donald Trump has said he may support a bipartisan bill, seeking an end to the federal ban on cannabis. The move could redefine the marijuana industry and put a stop to the threat of a crackdown by the Justice Department.
Trump spoke about the possibilities of extending support to the congressional effort to a group of reporters on June 8, 2018. His comments come after a bipartisan group of legislators, including Republican senator Cory Gardner, gave their suggestions. “I support Senator Gardner. I know exactly what he’s doing,” the President said. “We’re looking at it. But I probably will end up supporting that.”
Gardner, one of the lead sponsors of the bill, happens to be aligned with the White House on multiple issues. Stressing the need to do away the conflict between state and federal laws over marijuana legalization, Gardner said, “It is time we take this industry out of the shadows, bring these dollars out of the shadows.” Moreover, Democratic senator Elizabeth Warren, who is also a sponsor of the bill, believes the proposed legislation has the potential to restructure the legal landscape for cannabis upon becoming law.
Currently, nine states, including California, and the District of Columbia have decriminalized adult use of marijuana. Besides, an additional 20 states allow marijuana use for medical purposes, even though it continues to be classified as a Schedule I drug by the U.S. Food and Drug Administration (FDA). In January 2018, Sessions repealed an Obama-era memo that restricted federal prosecutors from taking action against marijuana dealers who run their businesses legally under state laws. Sessions had warned that prosecutors could target any cannabis establishment, irrespective of whether weed was legal in their state or not.
Experts say that an end to the federal prohibition of marijuana could boost efforts to introduce standard testing and regulatory practices for the drug, permitting scientists to focus more on research involving medical cannabis. Despite the wide acceptance of marijuana in many circles, the FDA has neither recognized nor approved its medicinal value. As per the FDA, so far, pharmacologists have not conducted extensive clinical trials to determine the medicinal value of marijuana, which could outweigh the possible health risks.
Fighting marijuana use disorder
Marijuana is a highly addictive substance with a range of side effects. Studies have revealed the presence of delta-9-tetrahydrocannabinol (THC), a neurotoxin, in marijuana. Frequent use can lead to abuse and addiction, as individuals are unable to discontinue the use of marijuana despite the harmful effects on their life. Marijuana modifies the reward system of the brain by inducing a dopamine rush, which automatically tweaks the brain for a heightened response to other drugs. Chronic pot users often require proper medical assistance to come out of its stronghold.
Research shows that marijuana use over a period can cause significant damage to short-term memory, motor coordination and respiratory tract. Also, attention deficits and problems with dexterity are common among chronic pot users. Under such circumstances, the help of a recognized drug addiction treatment clinic can be really beneficial in kicking weed addiction forever.
Sovereign Health understands the plight of someone unable to discontinue the use of harmful substances despite the negative impact on his or her life. Treatment programs at our marijuana addiction rehab centers are designed to help foster recovery in a holistic manner. If you or your loved one is battling marijuana addiction, call our 24/7 helpline or chat online to know about our evidence-based marijuana addiction treatment.
Reach Out To Us Today! Most Private Insurance Accepted